Micro Cap Growth Fund
Daily price w/o sales charge as of 06/18/2025
$16.02
$0.09
YTD Returns w/o sales charge as of 06/18/2025
-8.98%
Please click here for performance current to the most recent quarter-end and month-end.
Summary
Summary
Fund Basicsas of 05/30/2025
- Total Net Assets
- $174.42 M
- Inception Date
- 05/01/2000
- Dividend Frequency
- Annually
- Fund Gross Expense Ratio
- 1.38%
- Fund Net Expense Ratio
- 1.38%
- Number of Holdings
- 73
- Minimum Initial Investment
- $1,500+
Fund Expense Ratio :
Gross 1.38%
Net 1.38%
YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 05/01/2000 |
---|
w/o sales charge | -9.26% | 7.11% | 7.57% | 8.93% | 10.27% | 9.67% |
Lipper Category Avg. Small-Cap Growth Funds | -5.85% | 2.31% | 6.33% | 6.89% | 7.71% | - |
Russell Microcap® Growth Index | -8.00% | 8.78% | 5.88% | 4.88% | 3.63% | - |
w/ sales charge | -14.46% | 0.95% | 5.47% | 7.65% | 9.62% | 9.41% |
Fund Expense Ratio :
Gross 1.38%
Net 1.38%
Fund Expense Ratio :
Gross 1.38%
Net 1.38%
YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 05/01/2000 |
---|
w/o sales charge | -17.90% | -3.22% | -1.95% | 13.85% | 9.46% | 9.30% |
Lipper Category Avg. Small-Cap Growth Funds | -10.55% | -5.61% | -0.42% | 11.22% | 7.24% | - |
Russell Microcap® Growth Index | -17.75% | -5.93% | -3.79% | 8.16% | 2.70% | - |
w/ sales charge | -22.60% | -8.78% | -3.88% | 12.52% | 8.81% | 9.04% |
Fund Expense Ratio :
Gross 1.38%
Net 1.38%
Returns with sales charges reflect a maximum sales charge of 5.75%.
Past performance is not a reliable indicator or guarantee of future results. Current performance may be higher or lower than the performance data quoted. Returns shown include the reinvestment of all distributions. Returns shown at net asset value do not reflect the current maximum sales charge, had the sales charge been included, returns would have been lower. The investment return and principal value of an investment will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than the original cost.
TEN LARGEST HOLDINGS as of 05/30/2025View Portfolio
Holding | Assets |
---|---|
Argan Inc | 3.4% |
Grindr Inc | 3.0% |
Paymentus Holdings Inc | 2.9% |
Limbach Holdings Inc | 2.7% |
Universal Technical Institute Inc | 2.6% |
Life360 Inc | 2.6% |
CRA International Inc | 2.5% |
Tarsus Pharmaceuticals Inc | 2.5% |
Natural Grocers by Vitamin Cottage Inc | 2.5% |
OSI Systems Inc | 2.3% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Sector Allocationas of 05/30/2025View Portfolio
Sector | Weighting |
---|
Sector | Weighting |
---|---|
Communication Services | |
Other | |
Real Estate | |
Utilities | |
Consumer Discretionary | |
Consumer Staples | |
Energy | |
Financials | |
Health Care | |
Industrials | |
Information Technology | |
Materials |
INVESTMENT TEAM



Your Representative
To contact your representative, enter your zip code and select your channel below.
Performance
Performance
Fund Expense Ratio :
Gross 1.38%
Net 1.38%
YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 05/01/2000 |
---|
w/o sales charge | -9.26% | 7.11% | 7.57% | 8.93% | 10.27% | 9.67% |
Lipper Category Avg. Small-Cap Growth Funds | -5.85% | 2.31% | 6.33% | 6.89% | 7.71% | - |
Russell Microcap® Growth Index | -8.00% | 8.78% | 5.88% | 4.88% | 3.63% | - |
w/ sales charge | -14.46% | 0.95% | 5.47% | 7.65% | 9.62% | 9.41% |
Fund Expense Ratio :
Gross 1.38%
Net 1.38%
Fund Expense Ratio :
Gross 1.38%
Net 1.38%
YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 05/01/2000 |
---|
w/o sales charge | -17.90% | -3.22% | -1.95% | 13.85% | 9.46% | 9.30% |
Lipper Category Avg. Small-Cap Growth Funds | -10.55% | -5.61% | -0.42% | 11.22% | 7.24% | - |
Russell Microcap® Growth Index | -17.75% | -5.93% | -3.79% | 8.16% | 2.70% | - |
w/ sales charge | -22.60% | -8.78% | -3.88% | 12.52% | 8.81% | 9.04% |
Fund Expense Ratio :
Gross 1.38%
Net 1.38%
Returns with sales charges reflect a maximum sales charge of 5.75%.
Past performance is not a reliable indicator or guarantee of future results. Current performance may be higher or lower than the performance data quoted. Returns shown include the reinvestment of all distributions. Returns shown at net asset value do not reflect the current maximum sales charge, had the sales charge been included, returns would have been lower. The investment return and principal value of an investment will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than the original cost.
Year | Fund Returns | Russell Microcap® Growth Index |
---|
2024 | 26.89% | 21.91% |
2023 | 5.88% | 9.11% |
2022 | -29.27% | -29.76% |
2021 | 3.46% | 0.88% |
2020 | 79.42% | 40.13% |
2019 | 34.57% | 23.33% |
2018 | 2.74% | -14.18% |
2017 | 38.43% | 16.65% |
2016 | 2.07% | 6.86% |
2015 | -6.38% | -3.85% |
2014 | 10.83% | - |
2013 | 78.53% | - |
2012 | 2.35% | - |
2011 | -5.87% | - |
2010 | 33.77% | - |
2009 | 52.61% | - |
2008 | -46.45% | - |
2007 | 22.76% | - |
2006 | 25.37% | - |
2005 | 2.55% | - |
Year | Q1 | Q2 | Q3 | Q4 |
---|
2025 | -17.90% | - | - | - |
2024 | 7.64% | 0.07% | 6.89% | 10.21% |
2023 | 5.50% | 4.20% | -13.40% | 11.23% |
2022 | -17.22% | -22.57% | 8.17% | 2.02% |
2021 | 12.29% | -0.15% | -9.42% | 1.87% |
2020 | -24.28% | 47.61% | 17.48% | 36.65% |
2019 | 22.67% | 7.47% | -13.91% | 18.57% |
2018 | 5.24% | 15.77% | 10.08% | -23.39% |
2017 | 9.00% | 8.12% | 13.61% | 3.39% |
2016 | -13.70% | 6.01% | 14.49% | -2.55% |
2015 | 7.33% | 4.15% | -16.30% | 0.06% |
2014 | 7.92% | -6.53% | -6.55% | 17.58% |
2013 | 21.83% | 15.00% | 17.29% | 8.65% |
2012 | 17.67% | -9.76% | 1.32% | -4.87% |
2011 | 4.82% | 0.11% | -21.90% | 14.86% |
2010 | 6.60% | -8.74% | 15.08% | 19.49% |
2009 | -0.95% | 31.46% | 13.47% | 3.29% |
2008 | -23.22% | 4.46% | -5.93% | -29.02% |
2007 | 5.64% | 9.81% | 4.01% | 1.76% |
2006 | 17.15% | -9.83% | 1.22% | 17.25% |
2005 | -9.50% | 5.88% | 6.91% | 0.10% |
2004 | 12.33% | 1.65% | -11.11% | 24.03% |
2003 | -3.55% | 27.29% | 11.68% | 8.93% |
2002 | -0.18% | -12.74% | -21.79% | 1.33% |
2001 | 2.34% | 12.03% | -21.11% | 29.32% |
Performance is shown for each quarter and each calendar year. Past performance is no guarantee of future results.
Growth of $10,000 as of 05/31/2025
The chart begins on the Fund's inception date of 05/01/2000.
Based on a hypothetical Class A share investment of $10,000 on 05/01/2000 without sales charge and includes the reinvestment of all distributions.
NAV Historical Prices
Date | Net Asset Value |
---|
Portfolio
Portfolio
Holding | Sector | Assets |
---|
Argan Inc | Industrials | 3.4% |
Grindr Inc | Communication Services | 3.0% |
Paymentus Holdings Inc | Financials | 2.9% |
Limbach Holdings Inc | Industrials | 2.7% |
Universal Technical Institute Inc | Consumer Discretionary | 2.6% |
Life360 Inc | Information Technology | 2.6% |
CRA International Inc | Industrials | 2.5% |
Tarsus Pharmaceuticals Inc | Health Care | 2.5% |
Natural Grocers by Vitamin Cottage Inc | Consumer Staples | 2.5% |
OSI Systems Inc | Information Technology | 2.3% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Holding | Sector | Assets |
---|
Tarsus Pharmaceuticals Inc | Health Care | 4.0% |
Universal Technical Institute Inc | Consumer Discretionary | 3.5% |
Grindr Inc | Communication Services | 3.1% |
Natural Grocers by Vitamin Cottage Inc | Consumer Staples | 2.7% |
Paymentus Holdings Inc | Financials | 2.6% |
OSI Systems Inc | Information Technology | 2.6% |
Argan Inc | Industrials | 2.4% |
CRA International Inc | Industrials | 2.3% |
Scholar Rock Holding Corp | Health Care | 2.2% |
Mirum Pharmaceuticals Inc | Health Care | 2.2% |
Stride Inc | Consumer Discretionary | 2.1% |
Grid Dynamics Holdings Inc | Information Technology | 2.1% |
Chefs' Warehouse Inc/The | Consumer Staples | 2.0% |
Limbach Holdings Inc | Industrials | 2.0% |
Kratos Defense & Security Solutions Inc | Industrials | 2.0% |
Vita Coco Co Inc/The | Consumer Staples | 2.0% |
Life360 Inc | Information Technology | 1.9% |
Alkami Technology Inc | Information Technology | 1.8% |
Cellebrite DI Ltd | Information Technology | 1.7% |
Rhythm Pharmaceuticals Inc | Health Care | 1.7% |
Weave Communications Inc | Information Technology | 1.7% |
Oddity Tech Ltd | Consumer Staples | 1.7% |
Marex Group PLC | Financials | 1.7% |
PAR Technology Corp | Information Technology | 1.7% |
Travere Therapeutics Inc | Health Care | 1.6% |
IMAX Corp | Communication Services | 1.6% |
Sterling Infrastructure Inc | Industrials | 1.6% |
Arcellx Inc | Health Care | 1.5% |
Powell Industries Inc | Industrials | 1.5% |
Vital Farms Inc | Consumer Staples | 1.4% |
VSE Corp | Industrials | 1.4% |
Willdan Group Inc | Industrials | 1.3% |
Artivion Inc | Health Care | 1.3% |
Adaptive Biotechnologies Corp | Health Care | 1.3% |
Payoneer Global Inc | Financials | 1.3% |
Powerfleet Inc NJ | Information Technology | 1.3% |
GeneDx Holdings Corp | Health Care | 1.3% |
QuinStreet Inc | Communication Services | 1.2% |
PROCEPT BioRobotics Corp | Health Care | 1.2% |
Opera Ltd | Information Technology | 1.2% |
CareDx Inc | Health Care | 1.2% |
Piper Sandler Cos | Financials | 1.2% |
Phreesia Inc | Health Care | 1.2% |
Calix Inc | Information Technology | 1.0% |
Ambarella Inc | Information Technology | 1.0% |
Veracyte Inc | Health Care | 1.0% |
Primoris Services Corp | Industrials | 1.0% |
OneSpaWorld Holdings Ltd | Consumer Discretionary | 0.9% |
Core Scientific Inc | Information Technology | 0.9% |
Soleno Therapeutics Inc | Health Care | 0.8% |
Evolus Inc | Health Care | 0.8% |
UFP Technologies Inc | Health Care | 0.8% |
Credo Technology Group Holding Ltd | Information Technology | 0.8% |
NeuroPace Inc | Health Care | 0.8% |
TWFG Inc | Financials | 0.7% |
Sweetgreen Inc | Consumer Discretionary | 0.7% |
Kestra Medical Technologies Ltd | Health Care | 0.7% |
Ceribell Inc | Health Care | 0.7% |
Huron Consulting Group Inc | Industrials | 0.6% |
Vericel Corp | Health Care | 0.6% |
Viant Technology Inc | Information Technology | 0.6% |
Janux Therapeutics Inc | Health Care | 0.6% |
Xenon Pharmaceuticals Inc | Health Care | 0.6% |
LENZ Therapeutics Inc | Health Care | 0.6% |
Agilysys Inc | Information Technology | 0.5% |
Enliven Therapeutics Inc | Health Care | 0.5% |
Twist Bioscience Corp | Health Care | 0.5% |
Vera Therapeutics Inc | Health Care | 0.5% |
Butterfly Network Inc | Health Care | 0.5% |
Beta Bionics Inc | Health Care | 0.4% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Sector Allocationas of 05/30/2025
Sector | Weighting | Fund Change from Previous Quarter |
---|
Sector | Weighting | Fund Change from Previous Quarter |
---|---|---|
Communication Services |
![]() |
|
Other | 0.0% | |
Real Estate | 0.0% | |
Utilities | 0.0% | |
Consumer Discretionary |
![]() |
|
Consumer Staples |
![]() |
|
Energy | 0.0% | |
Financials |
![]() |
|
Health Care |
![]() |
|
Industrials |
![]() |
|
Information Technology |
![]() |
|
Materials | 0.0% |
Portfolio Details as of 05/30/2025
- Total Net Assets
- $174.42 M
- Number of Holdings
- 73
- Weighted Average Market Cap.
- 2.8 B
- P/B Ratio
- 5.3x
- P/E Ratio
- 34.6x
To view definitions for the above Portfolio Details, Click here.
P/B Ratio - A ratio that helps determine whether a stock is undervalued or overvalued. It is calculated by dividing a stock's price per share by its book value per share. The result is based upon a weighted average of the securities held in the fund.
P/E Ratio - Is the weighted average of each holding's P/E ratio (price of a stock divided by its earnings per share). The result is based upon a weighted average of the securities held in the fund.
Weighted Average Market Cap - The average market capitalization of all companies held in the portfolio with each company weighted according to its percent held in the portfolio. The result is based upon a weighted average of the securities held in the fund.
Dividends & Cap Gains
Dividends & Cap Gains
Dividend Payments
- YTD Dividends Paidas of 06/18/2025
- $0
- Dividend Frequency
- Annually
Record Date | Ex-Dividend Date | Reinvest & Payable Date | Dividend | Reinvest Price |
---|---|---|---|---|
11/20/2001 | 11/21/2001 | 11/21/2001 | $0.00740 | $10.09 |
Upcoming Dividend Payment Dates
This section lists all anticipated Income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.
Record Date | Ex-Dividend Date | Reinvest & Payable Date |
---|---|---|
12/01/2025 | 12/02/2025 | 12/02/2025 |
Capital Gains Distributions
Record Date | Reinvest & Payable Date | Long-term | Short-term * | Total | Reinvest Price |
---|---|---|---|---|---|
11/23/2020 | 11/24/2020 | $2.8043 | $2.2741 | $5.0784 | $15.43 |
Taxed as ordinary income
Lord Abbett does not provide tax advice. It is strongly recommended that you discuss the impact of dividends and distributions with your tax advisor.
Fees & Expenses
Fees & Expenses
Sales Charge Schedule as of 06/18/2025
Sales Charge | Dealer's Concession | Prices at Breakpoint | |
---|---|---|---|
Less than $50,000 | 5.75% | 5.00% | $17.00 |
$50,000 to $99,999 | 4.75% | 4.00% | $16.82 |
$100,000 to $249,999 | 3.95% | 3.25% | $16.68 |
$250,000 to $499,999 | 2.75% | 2.25% | $16.47 |
$500,000 to $999,999 | 1.95% | 1.75% | $16.34 |
$1,000,000 to $5,000,000 | 0.00% | 1.00% | $16.02 |
The 12b-1 trail commission is 0.15% (accrues immediately) for all fixed-income and municipal income funds.
Class A shares purchased without a sales charge (commissionable NAV) will be subject to a CDSC of 1% if they are redeemed before the first day of the month in which the one-year anniversary of the purchase falls.
Expense Ratioas of 05/31/2025
Fund Gross Expense Ratio | 1.38% |
Fund Net Expense Ratio | 1.38% |
Fund Documents
Fund Documents
0Documents selected
|
||||
---|---|---|---|---|
Portfolio Holdings 1Q
Publish Date:11/03/2015
|
||||
Portfolio Holdings 3Q
Publish Date:11/03/2015
|
||||
Summary Prospectus
Publish Date:11/03/2015
|
||||
Statutory Prospectus
Publish Date:11/03/2015
|
||||
SAI
Publish Date:11/03/2015
|
||||
Annual Financial Statements and Other Information *
Publish Date:11/03/2015
|
||||
Annual Tailored Shareholder Report
Publish Date:11/03/2015
|
||||
Semi-Annual Financial Statements and Other Information *
Publish Date:11/03/2015
|
||||
Fact Sheet
Publish Date:11/03/2015
|